NationalICMR Distances Itself From BHU's 'Poorly Designed' Study On Covaxin Side EffectsBY Asmita Ravi Shankar
InternationalAstraZeneca's Covid-19 Vaccine Can Cause A Second 'Rare' Blood Clotting Disorder? | What Research SaysBY Jheelum Basu
InternationalAstraZeneca Rolls Back Covid-19 Vaccine Amid Row Over Side- Effects, Terms It 'Purely Coincidental'BY Outlook News Desk
NationalBharat Biotech Highlights Covaxin's 'Safety First' Feature Amid AstraZeneca's Covishield Row Over Side EffectsBY Outlook News Desk
NationalPM Modi's Pic Disappears From CoWIN Certificates Amid Covishield Side Effects Row; Health Ministry RespondsBY Outlook News Desk
International'Sympathy To Those Who Lost Loved Ones': AstraZeneca On Covishield Side EffectsBY Outlook News Desk
National'Who Would Be Responsible For Heart Attack Deaths': Oppn Parties Slam BJP Over Covishield RowBY PTI
InternationalCovishield Maker AstraZeneca Admits Its Covid Vaccine Can Cause Rare Side EffectsBY Outlook News Desk
NationalSerum Institute Seeks Inclusion Of Covovax On CoWIN As Heterologous Booster Dose For AdultsBY PTI
NationalCovovax Booster Dose For Covid-19, Its Efficacy Rate And How Does It Work? All You Need To KnowBY Outlook News Desk
NationalCorbevax As Booster Maximises Protection In Covishield Vaccinated People: AIG Hospitals StudyBY PTI
NationalGovernment Not Liable For Vaccine-Related Deaths: Centre To Supreme CourtBY Outlook News Desk
NationalTelangana Asks Centre To Supply 50 Lakh Doses Of Covishield To Ramp Up Booster JabsBY Outlook News Desk
NationalImmunity From Natural Covid Infection, Vaccines Not Absolute: Minister of State for HealthBY Outlook News Desk
NationalBiological E Seeks EUA For Corbevax As Booster In Adults Vaccinated With Covishield, CovaxinBY Outlook News Desk
NationalSII To Give Free Covishield Vials To Pvt Vaccination Centres To Compensate For Price DifferenceBY Outlook News Desk
NationalSecond Covishield Dose Can Be Given Between 8-16 Weeks After First Dose, Says NTAGI Reducing GapBY Outlook News Desk
NationalCovishield And Covaxin Get Regular Market Approval For Use In Adult PopulationBY Outlook News Desk
NationalRegular Market Approval Likely To Cap Covishield, Covaxin Price At Rs 275BY Outlook News Desk
